PresentationI would now like to turn the call over to Laurence Watts of New Street Investor Relations. Please go ahead.Hello, and welcome to the Immuneering conference call to discuss the positive 9-month update announced last week from the company's ongoing Phase IIa trial of atebemetinib and first-line pancreatic cancer patients. [Operator Instructions] As a reminder, this call is being recorded today, Monday, September 29, 2025.Laurence Watts Thank you, operator. Joining us on the call today from Immunee ...